Scale | PPMS (n = 104) | Rehabilitation (n = 64) | Steroids (n = 77) | χ2* (DR)† |
---|---|---|---|---|
*χ2 values from Kruskal Wallis ANOVA; †DR (differential responsiveness) = pairwise χ2 values (for example, for SF-36MH = 100×22.4/56.9); ‡ES, effect size; SRM, standardised response mean; §z values from Wilcoxon’s signed ranks test; ¶RE (relative efficiency) = pairwise square z values (for example, for SF-36MH in rehabilitation = 100×(−3.441)2/(−4.954)2). | ||||
MSIS-29 | n = 85 | n = 60 | n = 65 | 39.8 (70%) |
ES (SRM)‡ | −0.15 (−0.16) | 0.44 (0.54) | 0.72 (0.90) | |
z value (p)§ | −1.286 (0.199) | −3.647 (0.000) | −5.826 (0.000) | |
RE¶ | 54% | 96% | ||
SF-36MH | n = 81 | n = 60 | n = 64 | 22.4 (39%) |
ES (SRM) | −0.13 (−0.17) | 0.31 (0.48) | 0.44 (0.53) | |
z value (p) | −1.448 (0.148) | −3.441 (0.001) | −4.138 (0.000) | |
RE | 48% | 49% | ||
FAMS EWB | n = 85 | n = 60 | n = 65 | 21.5 (38%) |
ES (SRM) | −0.04 (−0.05) | 0.52 (0.71) | 0.38 (0.50) | |
z value (p) | −0.408 (0.683) | −4.710(0.000) | −3.981 (0.000) | |
RE | 90% | 45% | ||
GHQ-12 | n = 86 | n = 60 | n = 65 | 56.9 (100%) |
ES (SRM) | −0.15 (−0.17) | 0.60 (0.79) | 0.87 (0.94) | |
z value (p) | −1.392 (0.164) | −4.954 (0.000) | −5.939 (0.000) | |
RE | 100% | 100% |